Altropane (Boston Life Science).

Article Details

Citation
Copy to clipboard

Cattabeni F

Altropane (Boston Life Science).

Curr Opin Investig Drugs. 2002 Nov;3(11):1647-51.

PubMed ID
12476968 [ View in PubMed
]
Abstract

Boston Life Sciences (BLS) is developing Altropane as a potential radio-imaging agent to be used with single photon emission tomography (SPECT), for the early diagnosis of Parkinson's disease (PD) and attention deficit hyperactivity disorder (ADHD) [329661]. Altropane is currently in phase III clinical trials for PD and phase II clinical trials for ADHD.

DrugBank Data that Cites this Article

Drugs